IMPFSTOFF GEGEN HPV

European patent · EP2318042 · In force

Register entry

Publication number
EP2318042
Application number
EP09781248
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 29, 2009
Published
May 11, 2011
Granted
Aug 20, 2014
Protection ends at the latest
Jul 28, 2029
Next annual fee due
Jul 31, 2027
IPC classes
A61K 39/12 (2006.01)
A61P 35/00 (2006.01)
Priority
US 85101 P 31.07.2008
US 176561 P 08.05.2009
PCT application
PCT/EP2009/059820 29.07.2009
PCT publication
WO2010/012780 04.02.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Oct 22, 2014

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 22.10.2014

  7. Aug 20, 2014

    Granted

    Published in Swissreg on 20.08.2014

Parties

Holder

GlaxoSmithKline Biologicals S.A.

rue de l'Institut, 89, 1330 Rixensart, BE

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

DESCAMPS, Dominique

B-1330 Rixensart, BE

GIANNINI, Sandra

B-1330 Rixensart, BE

LECRENIER, Nicolas

B-1330 Rixensart, BE

STEPHENNE, Jean

B-1330 Rixensart, BE

WETTENDORFF, Martine Anne Cecile

B-1330 Wavre, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.